Oncothyreon (ONTY +2.1%) announces the filing of an Investigational New Drug application with the FDA for ONT-10, a therapeutic vaccine directed at cancers expressing MUC1. Upon completion of the review, expects to initiate a Phase 1 trials.
From other sites
at CNBC.com (Feb 24, 2012)
at CNBC.com (Jun 24, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs